S. Gracon
Impact in
- Psychiatry and Mental health top 2%
- Dementia and Cognitive Impairment Research
- Pharmacology top 2%
- Cholinesterase and Neurodegenerative Diseases
Papers in
-
- Cholinesterase and Neurodegenerative Diseases 4
-
- Alzheimer's disease research and treatments 3
- Sympathectomy and Hyperhidrosis Treatments 1
- Co-authors
- Toni M. Hoover (4 shared papers)David S. Knopman (3 shared papers)Keith L. Davis (2 shared papers)Fraser Smith (1 shared paper)Sheela Talwalker (1 shared paper)Lon S. Schneider (1 shared paper)E. Gamzu (3 shared papers)Robert F. Woolson (1 shared paper)
- Journals
- Neurology (3 papers)JAMA (1 paper)Toxicology and Applied Pharmacology (1 paper)The Lancet (1 paper)Pharmacopsychiatry (1 paper)
- Partner nations
- United StatesCanadaAustralia
In The Last Decade
S. Gracon
11 papers receiving 966 citations
S. Gracon's Hit Papers
Peers
Comparison fields: 5 of 87
- Psychiatry and Mental health 380
- Pharmacology 352
- Physiology 322
- Neurology 103
- Geriatrics and Gerontology 38
Countries citing papers authored by S. Gracon
This map shows the geographic impact of S. Gracon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Gracon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Gracon more than expected).
Fields of papers citing papers by S. Gracon
This network shows the impact of papers produced by S. Gracon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Gracon. The network helps show where S. Gracon may publish in the future.
Co-authors
The 25 scholars most cited alongside S. Gracon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | A Double-Blind, Placebo-Controlled Multicenter Study of Tacrine for Alzheimer's Disease Hit paper breakdown → | 1992 | 477 |
| 2 | 1996 | 231 | |
| 3 | 2003 | 226 | |
| 4 | 2011 | 54 | |
| 5 | 1996 | 15 | |
| 6 | 1991 | 9 | |
| 7 | 1998 | 6 | |
| 8 | 1982 | 5 | |
| 9 | 1996 | 3 | |
| 10 | 1993 | 3 | |
| 11 | 1988 | 1 | |
| 12 | 1990 | 1 |
About S. Gracon
S. Gracon is a scholar working on Pharmacology, Physiology, Psychiatry and Mental health, Molecular Biology and Oncology, having authored 12 papers that have together received 1.0k indexed citations. Recurring topics across this work include Cholinesterase and Neurodegenerative Diseases (4 papers), Alzheimer's disease research and treatments (3 papers), Dementia and Cognitive Impairment Research (3 papers), Olfactory and Sensory Function Studies (2 papers), Glaucoma and retinal disorders (1 paper), Neuroscience and Neural Engineering (1 paper), Sympathectomy and Hyperhidrosis Treatments (1 paper) and Memory and Neural Mechanisms (1 paper). The work is most often cited by research in Psychiatry and Mental health (380 citations), Pharmacology (352 citations), Physiology (322 citations), Neurology (103 citations) and Geriatrics and Gerontology (38 citations). S. Gracon has collaborated with scholars based in United States, Canada and Australia. Frequent co-authors include Toni M. Hoover, David S. Knopman, Keith L. Davis, Fraser Smith, Sheela Talwalker, Lon S. Schneider, E. Gamzu, Lon S. Schneider, Robert F. Woolson and Ch Davis. Their work appears in journals such as Neurology, JAMA, Toxicology and Applied Pharmacology, The Lancet and Pharmacopsychiatry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.